Interpace Biosciences, Inc. (IDXG)
OTCMKTS: IDXG · Delayed Price · USD
1.540
+0.117 (8.26%)
Apr 26, 2024, 11:24 AM EDT - Market open

Interpace Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Cash & Equivalents
3.54.833.312.772.326.0715.20.68.3123.11
Upgrade
Short-Term Investments
000000000.110.11
Upgrade
Cash & Cash Equivalents
3.54.833.312.772.326.0715.20.68.4223.22
Upgrade
Cash Growth
-27.55%45.68%19.55%19.43%-61.75%-60.08%2424.75%-92.85%-63.75%-49.24%
Upgrade
Receivables
4.985.036.168.0310.29.483.442.533.8514.42
Upgrade
Inventory
1.231.221.792.051.831.230.270.015.550
Upgrade
Other Current Assets
0.611.070.911.272.030.940.911.091.347.23
Upgrade
Total Current Assets
10.3212.1512.1714.1216.3717.7219.814.2419.1744.87
Upgrade
Property, Plant & Equipment
2.652.9210.3811.7310.710.840.650.931.463.18
Upgrade
Long-Term Investments
000000000.911.06
Upgrade
Goodwill
008.438.438.43000015.55
Upgrade
Intangible Assets
00.867.2911.3533.529.8533.1136.3643.4947.3
Upgrade
Other Long-Term Assets
0.050.050.160.040.040.030.030.252.693.95
Upgrade
Total Long-Term Assets
2.73.8326.2631.5652.6830.7233.7937.5448.5571.04
Upgrade
Total Assets
13.0215.9838.4345.6869.0548.4453.641.7867.71115.91
Upgrade
Accounts Payable
1.541.052.694.514.811.060.392.331.564.31
Upgrade
Deferred Revenue
0.2600.040.050.460008.396.75
Upgrade
Current Debt
5.483.081.121.21.510001.1619.7
Upgrade
Other Current Liabilities
10.1910.1611.8312.4610.527.437.613.9212.262.82
Upgrade
Total Current Liabilities
17.4714.2815.6818.2317.38.497.9916.2423.3733.58
Upgrade
Long-Term Debt
4.2413.0112.63.545.59007.917.2327.15
Upgrade
Other Long-Term Liabilities
6.4451.7652.5752.9933.147.015.6411.124.0735.05
Upgrade
Total Long-Term Liabilities
10.6864.7765.1656.5338.737.015.6419.0131.362.21
Upgrade
Total Liabilities
28.1679.0580.8574.7656.0315.513.6335.2554.6795.78
Upgrade
Total Debt
11.1916.0913.724.747.1007.918.427.15
Upgrade
Debt Growth
-30.45%17.32%189.12%-33.15%----5.82%-69.08%-
Upgrade
Common Stock
0.410.410.40.40.390.290.280.020.190.17
Upgrade
Retained Earnings
-248.22-249.02-227.06-212.12-168.16-141.49-131.8-119.58-111.25-99.9
Upgrade
Comprehensive Income
-46.5400-45.68-26.17-1.37-1.16-00.010.02
Upgrade
Shareholders' Equity
-15.14-63.07-42.42-29.0813.0332.9439.976.5313.0420.12
Upgrade
Total Liabilities and Equity
13.0215.9838.4345.6869.0548.4453.641.7867.71115.91
Upgrade
Net Cash / Debt
-7.69-11.26-10.4-1.97-4.786.0715.2-7.310.02-3.94
Upgrade
Net Cash / Debt Growth
------60.08%----
Upgrade
Net Cash Per Share
-1.76-2.66-2.52-0.49-1.272.159.64-40.230.12-26.41
Upgrade
Working Capital
-7.15-2.13-3.52-4.11-0.939.2311.82-12-4.2111.29
Upgrade
Book Value Per Share
-3.51-14.88-10.26-7.223.4811.7025.4235.9684.25135.04
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.